Science Magazine named as last year’s scientific “Breakthrough of the Year” an international study showing that early initiation of HIV treatment greatly reduced the risk of onward transmission. In British Columbia, where researchers pioneered the treatment-as-prevention strategy, new HIV/AIDS cases are continuing to decline, recent data show.
“We’re particularly pleased to see our treatment-as-prevention strategy has taken off big-time,” said Dr. Julio S.G. Montaner, director of the British Columbia Center for Excellence in HIV/AIDS, which helped develop the approach. The province searched aggressively for at-risk populations, encouraging HIV testing among them and early treatment for those infected. Vancouver also supports a supervised injection center where drug users can receive medical care and testing.
Testing is increasing, so the decline in new cases is not due to fewer tests; also, syphilis rates are stable, suggesting condom use has not increased, Montaner said. The lack of donor support for treatment-as-prevention in poor countries with extensive epidemics is frustrating, he added.
The study referenced by Science involved a clinical trial of 1,763 serodiscordant couples on four continents. It found the early initiation of antiretroviral therapy reduced by 96 percent the chance of an infected partner passing on the virus.
The Friends of AIDS Foundation is dedicated to enhancing the quality of life for HIV positive individuals and empowering people to make healthy choices to prevent the spread of the HIV virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!